|
| GSK-467 Basic information |
Product Name: | GSK-467 | Synonyms: | cGAS inhibitor 467;GSK-467;2-((1-Benzyl-1H-pyrazol-4-yl)oxy)pyrido[3,4-d]pyrimidin-4(3H)-one;HCC,inhibit,GSK 467,GSK467,Histone Demethylase,GSK-467,human multiple myeloma tumor,anticancer,PLU1,Inhibitor,JARID1B;Pyrido[3,4-d]pyrimidin-4(3H)-one, 2-[[1-(phenylmethyl)-1H-pyrazol-4-yl]oxy]- | CAS: | 1628332-52-4 | MF: | C17H13N5O2 | MW: | 319.32 | EINECS: | | Product Categories: | | Mol File: | 1628332-52-4.mol | ![GSK-467 Structure](CAS/20210111/GIF/1628332-52-4.gif) |
| GSK-467 Chemical Properties |
Boiling point | 560.6±60.0 °C(Predicted) | density | 1.41±0.1 g/cm3(Predicted) | storage temp. | 2-8°C | solubility | DMSO : 20.83 mg/mL (65.23 mM);Water : < 0.1 mg/mL (insoluble) | pka | 2.27±0.20(Predicted) |
| GSK-467 Usage And Synthesis |
| GSK-467 Preparation Products And Raw materials |
|